» Articles » PMID: 23680136

[Morbidity and Drug Consumption. Comparison of Results Between the National Health Survey and Electronic Medical Records]

Overview
Journal Gac Sanit
Specialty Public Health
Date 2013 May 18
PMID 23680136
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the prevalence of disease and drug consumption obtained by using the National Health Survey (NHS) with the information provided by the electronic medical records (EMR) in primary health care and the Pharmaceutical Consumption Registry in Aragon (Farmasalud) in the adult population in the province of Zaragoza.

Methods: A cross-sectional study was performed to compare the prevalence of diseases in the NHS-2006 and in the EMR. The prevalence of drug consumption was obtained from the NHS-2006 and Farmasalud. Estimations using each database were compared with their 95% confidence intervals (95% CI) and the results were stratified by gender and age groups. The comparability of the databases was tested.

Results: According to the NHS, a total of 81.8% of the adults in the province of Zaragoza visited a physician in 2006. According to the EMR, 61.4% of adults visited a primary care physician. The most prevalent disease in both databases was hypertension (NHS: 21.5%, 95% CI: 19.4-23.9; EMR: 21.6%, 95% CI: 21.3-21.8). The greatest differences between the NHS and EMR was observed in the prevalence of depression, anxiety, and other mental illnesses (NHS: 10.9%; EMR: 26.6%). The most widely consumed drugs were analgesics The prevalence of drug consumption differed in the two databases, with the greatest differences being found in pain medication (NHS: 23.3%; Farmasalud: 63.8%) and antibiotics (NHS: 3.4%; Farmasalud: 41.7%). These differences persisted after we stratified by gender and were especially important in the group aged more than 75 years.

Conclusions: The prevalence of morbidity and drug consumption differed depending on the database employed. The use of different databases is recommended to estimate real prevalences.

Citing Articles

Identification of Hypertension in Electronic Health Records Through Computable Phenotype Development and Validation for Use in Public Health Surveillance: Retrospective Study.

Valvi N, McFarlane T, Allen K, Gibson P, Dixon B JMIR Form Res. 2023; 7:e46413.

PMID: 38150296 PMC: 10782284. DOI: 10.2196/46413.


Cross-national comparisons of health indicators require standardized definitions and common data sources.

Tolonen H, Reinikainen J, Koponen P, Elonheimo H, Palmieri L, Tijhuis M Arch Public Health. 2021; 79(1):208.

PMID: 34819157 PMC: 8614034. DOI: 10.1186/s13690-021-00734-w.


Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.

Menditto E, Gimeno Miguel A, Moreno Juste A, Poblador Plou B, Aza Pascual-Salcedo M, Orlando V PLoS One. 2019; 14(2):e0210701.

PMID: 30726245 PMC: 6364882. DOI: 10.1371/journal.pone.0210701.


Innovations in Population Health Surveillance: Using Electronic Health Records for Chronic Disease Surveillance.

Perlman S, McVeigh K, Thorpe L, Jacobson L, Greene C, Gwynn R Am J Public Health. 2017; 107(6):853-857.

PMID: 28426302 PMC: 5425902. DOI: 10.2105/AJPH.2017.303813.


Monitoring Prevalence, Treatment, and Control of Metabolic Conditions in New York City Adults Using 2013 Primary Care Electronic Health Records: A Surveillance Validation Study.

Thorpe L, McVeigh K, Perlman S, Chan P, Bartley K, Schreibstein L EGEMS (Wash DC). 2017; 4(1):1266.

PMID: 28154836 PMC: 5226388. DOI: 10.13063/2327-9214.1266.